CT texture analysis can help differentiate between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer

Abstract

Background

In patients with non-small-cell lung carcinoma NSCLC the lymph node staging in the mediastinum is important due to impact on management and prognosis. Computed tomography texture analysis (CTTA) is a postprocessing technique that can evaluate the heterogeneity of marked regions in images.

Purpose

To evaluate if CTTA can differentiate between malignant and benign lymph nodes in a cohort of patients with suspected lung cancer.

Material and Methods

With tissue sampling as reference standard, 46 lymph nodes from 29 patients were analyzed using CTTA. For each lymph node, CTTA was performed using a research software “TexRAD” by drawing a region of interest (ROI) on all available axial contrast-enhanced computed tomography (CT) slices covering the entire volume of the lymph node. Lymph node CTTA comprised image filtration-histogram analysis undertakes two stages: the first step comprised an application of a Laplacian of Gaussian filter to highlight fine to coarse textures within the ROI, followed by a quantification of textures via histogram analysis using mean gray-level intensity from the entire volume of the lymph nodes.

Results

CTTA demonstrated a statistically significant difference between the malignant and the benign lymph nodes (P = 0.001), and by binary logistic regression we obtained a sensitivity of 53% and specificity of 97% in the test population. The area under the receiver operating curve was 83.4% and reproducibility was excellent.

Conclusion

CTTA may be helpful in differentiating between malignant and benign lymph nodes in the mediastinum in patients suspected for lung cancer, with a low intra-observer variance.

Keywords

Computed tomography (CT)computer applications – detection/diagnosis thorax lymphatic mediastinum

Get full access to this article

View all access options for this article.

References

Harders

Madsen

Hjorthaug

. Characterization of pulmonary lesions in patients with suspected lung cancer: computed tomography versus [¹⁸F] fluorodeoxyglucose-positron emission tomography/computed tomography. Cancer Imaging 2012; 12: 437–446.

Harders

Madsen

Hjorthaug

. Mediastinal staging in non-small-cell lung carcinoma: computed tomography versus F-18-fluorodeoxyglucose positron-emission tomography and computed tomography. Cancer Imaging 2014; 14: 23–23.

Silvestri

Gonzalez

Jantz

. Methods for staging non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2013; 143: e211S–250S.

Darling

Maziak

Inculet

. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial. J Thorac Oncol 2011; 6: 1367–1372.

Y-L

Yuan

D-M

Wang

. Diagnostic performance of integrated positron emission tomography/computed tomography for mediastinal lymph node staging in non-small cell lung cancer: a bivariate systematic review and meta-analysis. J Thorac Oncol 2011; 6: 1350–1358.

Ganeshan

Abaleke

Young

RCD

. Texture analysis of non-small cell lung cancer on unenhanced computed tomography: initial evidence for a relationship with tumour glucose metabolism and stage. Cancer Imaging 2010; 10: 137–143.

Ganeshan

Panayiotou

Burnand

. Tumour heterogeneity in non-small cell lung carcinoma assessed by CT texture analysis: a potential marker of survival. Eur Radiol 2012; 22: 796–802.

Ganeshan

Skogen

Pressney

. Tumour heterogeneity in oesophageal cancer assessed by CT texture analysis: preliminary evidence of an association with tumour metabolism, stage, and survival. Clin Radiol 2012; 67: 157–164.

Ganeshan

Kozarski

. Assessment of primary colorectal cancer heterogeneity by using whole-tumor texture analysis: contrast-enhanced CT texture as a biomarker of 5-year survival. Radiology 2013; 266: 177–184.

10.

Zhang

Graham

Elci

. Locally advanced squamous cell carcinoma of the head and neck: CT texture and histogram analysis allow independent prediction of overall survival in patients treated with induction chemotherapy. Radiology 2013; 269: 801–809.

11.

Goh

Ganeshan

Nathan

. Assessment of response to tyrosine kinase inhibitors in metastatic renal cell cancer: CT texture as a predictive biomarker. Radiology 2011; 261: 165–171.

12.

Skogen

Ganeshan

Good

. Measurements of heterogeneity in gliomas on computed tomography relationship to tumour grade. J Neurooncol 2013; 111: 213–219.

13.

Bland

Altman

. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986 8; 1: 307–310.

14.

Prenzel

Mönig

Sinning

. Lymph node size and metastatic infiltration in non-small cell lung cancer. Chest 2003; 123: 463–467.

15.

Gómez-Caro

Boada

Cabañas

. False-negative rate after positron emission tomography/computer tomography scan for mediastinal staging in cI stage non-small-cell lung cancer. Eur J Cardiothorac Surg 2012; 42: 93–100discussion 100.

16.

Eisenhauer

Therasse

Bogaerts

. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 2009; 45: 228–247.

17.

Carrillo

Daniel

Hall

. Fusion positron emission/computed tomography underestimates the presence of hilar nodal metastases in patients with resected non-small cell lung cancer. Ann Thorac Surg 2012; 93: 1621–1624.

18.

Fernández-Esparrach

Sendino

. [New endoscopic ultrasound (EUS) applications in lung cancer: evaluation of patients with negative mediastinal CT and re-staging after neoadjuvant treatment]. Arch Bronconeumol 2011; 47: 410–414.

19.

Herth

FJF

. Nonsurgical staging of the mediastinum: EBUS and EUS. Semin Respir Crit Care Med 2011; 32: 62–68.

20.

Bayanati

E Thornhill

Souza

. Quantitative CT texture and shape analysis: can it differentiate benign and malignant mediastinal lymph nodes in patients with primary lung cancer? Eur Radiol 2015; 25: 480–487.